ResearchIn-Press PreviewImmunology
Open Access |
10.1172/jci.insight.208009
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by Li, D. in: PubMed | Google Scholar
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by Reay, D. in: PubMed | Google Scholar
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by
Pinal-Fernandez, I.
in:
PubMed
|
Google Scholar
|
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by Casal-Dominguez, M. in: PubMed | Google Scholar
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by Mammen, A. in: PubMed | Google Scholar
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by
Gaffen, S.
in:
PubMed
|
Google Scholar
|
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by Oriss, T. in: PubMed | Google Scholar
1Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
2National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, United States of America
Find articles by Ascherman, D. in: PubMed | Google Scholar
Published July 23, 2026 - More info
The precise mechanisms underlying the pathogenesis of idiopathic inflammatory myopathy (IIM) remain undefined. However, there has been increasing recognition that tissue-resident memory cells (TRMs) play an important role in the pathogenesis of systemic autoimmune disease. In IIM, TRM-associated transcriptional signatures have been reported, but on a very limited basis. By using multimodal single-cell RNA sequencing analysis in our established murine model of histidyl-tRNA synthetase (HRS)-induced myositis, we identified a prominent population of CD4+ TRMs in inflamed skeletal muscle. Muscle CD4+ TRMs exhibited high expression of genes encoding Cd69, Cxcr6, Runx3, and Prdm1, alongside low expression of Klf2, Ccr7, Sell, S1pr1, and Tcf7 — a profile that is generally consistent with previous reports of TRM gene signature and that we validate through comparison to transcriptomic profiles of human muscle tissue. Detailed pathway analysis in our model indicates that muscle CD4+ TRMs contribute to innate immune regulatory pathways enriched for TNF and IFN-γ signaling. Furthermore, analysis of TCR clonotype distribution and CDR3 sequence similarity revealed pronounced clonal expansion of CD4+ TRMs relative to other T-cell subsets — a pattern that remained stable from 2 to 6 weeks post-immunization. Collectively, these results suggest a potential role for CD4+ TRMs in the pathogenesis of autoimmune myositis.